Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel

Nicholas M Mohr; Ian D Plumb; Eliezer Santos León; Karisa K Harland; Anusha Krishnadasan; Utsav Nandi; Karin F Hoth; Howard A Smithline; David A Talan

doi:10.1080/21645515.2023.2284471

Back

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel

Journal article

Open access

Peer reviewed

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel

Nicholas M Mohr, Ian D Plumb, Eliezer Santos León, Karisa K Harland, Anusha Krishnadasan, Utsav Nandi, Karin F Hoth, Howard A Smithline and David A Talan

Human vaccines & immunotherapeutics, Vol.19(3), 2284471

12/15/2023

DOI: 10.1080/21645515.2023.2284471

PMCID: PMC10760319

PMID: 37994545

Files and links (1)

url

https://doi.org/10.1080/21645515.2023.2284471View

Published (Version of record) Open Access

Abstract

COVID-19 vaccination is effective at reducing SARS-CoV-2 complications, but uptake has been low. Our objective in this study was to compare the importance of factors reported to influence the decision to receive a bivalent COVID-19 booster vaccine among health care personnel (HCP) tested for SARS-CoV-2 between October 2022 and April 2023 in a 20-hospital vaccine effectiveness study in the United States (n = 1656). Compared with those who had not received the booster, the factors most likely to be reported to be important were concerns about contracting COVID-19 (84.0% of those who had received the bivalent booster vs. 47.5% of those who had not, difference 36.6% points (PP), 95% confidence interval [CI] 32.1 to 41.1%), spreading infection to family members (89.2% vs. 62.8%, difference 26.3 PP, 95% CI 22.3 to 30.4%), and spreading infection to colleagues at work (85.5% vs. 59.4%, difference 26.1 PP, 95% CI 21.7 to 30.5%). HCP who had received the booster more frequently cited the primary literature (61.7% vs. 31.8%, difference 29.9 PP, 95% CI 24.6 to 35.2%) and employer recommendations (48.3% vs. 29.8%, difference 18.5 PP, 95% CI 13.2 to 23.9%) as influencing their decision. This analysis provides insight into factors for targeting future vaccine messaging.

Details

Title: Subtitle: Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel
Creators: Nicholas M Mohr - University of Iowa
Ian D Plumb - Centers for Disease Control and Prevention
Eliezer Santos León - University of Iowa
Karisa K Harland - University of Iowa
Anusha Krishnadasan - Olive View-UCLA Medical Center
Utsav Nandi - University of Mississippi Medical Center
Karin F Hoth - University of Iowa
Howard A Smithline - University of Massachusetts Chan Medical School
David A Talan - University of Iowa
Resource Type: Journal article
Publication Details: Human vaccines & immunotherapeutics, Vol.19(3), 2284471
DOI: 10.1080/21645515.2023.2284471
PMID: 37994545
PMCID: PMC10760319
NLM abbreviation: Hum Vaccin Immunother
eISSN: 2164-554X
Grant note: DOI: 10.13039/100000030, name: Centers for Disease Control and Prevention, award: U01CK000643; DOI: 10.13039/100008893, name: University of Iowa; DOI: 10.13039/100006108, name: National Center for Advancing Translational Sciences; DOI: 10.13039/100000002, name: National Institutes of Health, award: UL1TR002537
Language: English
Date published: 12/15/2023
Academic Unit: Psychiatry; Epidemiology; Emergency Medicine; Iowa Neuroscience Institute; Anesthesia; Injury Prevention Research Center; Law Faculty; Internal Medicine
Record Identifier: 9984516559902771

Metrics

12 Record Views

3 Times Cited - Web of Science